8 hrs ago | BioSpace
BioMarin Pharmaceutical Inc. to Present at the Jefferies and Co. Global Healthcare Conference
NOVATO, Calif., May 29, 2012 -- BioMarin Pharmaceutical Inc. today announced that Joshua Grass, Senior Vice President of Corporate and Business Development at BioMarin, will present a company update at the Jefferies Global Healthcare Conference in New York on Monday, June 4, 2012 at 8:30 a.m. ET.
12 hrs ago | TheStreet.com
BioMarin Stock Hits New 52-Week High
NEW YORK -- BioMarin Pharmaceuticals hit a new 52-week high Tuesday as it is currently trading at $39.21, above its previous 52-week high of $39.20 with 149,677 shares traded as of 10:35 a.m. ET.
8 Biotechnology Stocks With Good Liquidity That Analysts Rate As Buy
Interested in biotechnology companies? Do you prefer companies with high liquidity? Do you prefer investing in stocks that analysts have weighed in on? We ran a screen you might find helpful.
6 High-Growth Biotech Stocks Analysts Rate As Buys
Interested in gaining exposure to biotechnology companies? Do you prefer stocks that are projected to grow over the long term? Do you prefer investing in stocks that analysts have weighed in on? If so, here's a list you might be interested in.
Planning Commissioner Kae Herries Running for Council
Planning Commissioner Alicia Kae Herries has announced her run for the Petaluma's city council and says mitigating traffic, balancing the budget and reforming city pensions are on the top of her to-do list.
s on the Move: Week Ending May 11
J.C. Penney, Philip Morris International, C.R. Bard, OSI Restaurant Partners, Furniture Brands International, PDL BioPharma, The Coffee Bean & Tea Leaf, Serena Software, BioMarin Pharmaceutical, Icon Aircraft J.C. Penney Co.
Zacks Reiterates "Neutral" Rating on Biomarin Pharm
's stock had its "neutral" rating restated by Zacks in a research report issued to clients and investors on Monday.